Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Neurolief , Ltd.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Neurolief , Ltd.

Regulatory records
1
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 1 FDA record to the applicant name Neurolief , Ltd.. It includes 1 original PMA approval. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Dec 31, 2025 to Dec 31, 2025. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code JXK appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P250010, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 12 Giborei Israel St., Netanya, 4250412. Recorded on P250010, decision dated Dec 31, 2025.

Changes described in PMA records

P250010: ProlivRx System

FDA’s recorded scope: The ProlivRx System provides focal external Combined Occipital and Trigeminal Afferent Stimulation (eCOT-AS) treatment. It is intended as an adjunctive treatment for Major Depressive Disorder (MDD) in adults who failed to achieve satisfactory improvement from at least one previous antidepressant medication, for use at home or in clinic. It is a prescription-only device.

Dec 31, 2025

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
Neurolief , Ltd.PMA approvalDec 31, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.